@C_W_Armstrong and Dr. Kathy Huang's potential diagnostic breakthrough is particularly exciting, as the data generated from this test could be instrumental in developing personalised treatments – a key strategy of the Melbourne ME/CFS Collaboration
Historic News from Emerge Australia! Federal Govt to update ME/CFS & Long COVID clinical guidelines, aiding 250,000+ Australians. CEO Anne Wilson applauds Minister Mark Butler. Collaboration with NHMRC for 2-3 year guideline development. Details HERE: https://t.co/qoyFO5ijJN
The stand out piece is the transfer of IgG from patients with pain creating a pain phenotype in mice with followed up indications of SFN. Excellent read!
Sharing our new study by @keylas3, @SilvaJ_C, Rafael Bayarri Olmos et al (with T. Horvath & @PutrinoLab) showing that a passive transfer of IgG from patients with #longCOVID into mice recapitulates ⬆️ pain and other symptoms 🧵 (1/)
https://t.co/J5I22Y4fnn
@VirusesImmunity Excellent piece of work, congratulations!
As an aside, I think chart E may have an incorrect annotation. n = 1 and n = 3 should be swapped.
Personalized Treatment Trials: Monitoring and Improving the Connection of Treatments to Patients
Learn more about this study from Chris Armstrong, PhD, Director of the Melbourne ME/CFS Collaboration 👉 https://t.co/a6D7VFpFfx
#pwME#mecfs#pwLC#LongCOVID#OMFResearch
@exceedhergrasp1@MECFSNews Yes, we are very excited. These guys have been doing fantastic work as evidenced by this paper. I'm currently working with them to do the metabolomics portion of this project.
It is with great sadness that we report the sudden passing of our friend and colleague, Dr. Jonas Blomberg. He saw the urgent need for research in this field and shared his passion with our ME/CFS community. Read Linda Tannenbaum's note to the community: https://t.co/CE2SK4AYRP
CD24 expression and B cell maturation shows a novel link with energy metabolism:
potential implications for patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome https://t.co/e9PmE5bpA9
@wigglethemouse@OpenMedF@Cara_717 Yes i am. This made me laugh though, I introduced Cara as being from Australia because of the bios, but that was a typo, she's from England 😂
@EndMECFS@PreciselyWell This is a symptom tracking up that also enables participants to register for research worldwide. Allows researchers to organise studies and send surveys through it. Working on finished product, hopefully in a month or so.